Lexpos News

Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Drug alert number: EL (24)A/36 Date issued: 12 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Company name: Star Pharmaceuticals Limited Product name: Diflucan Oral [...]

The post MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) appeared first on Community Pharmacy England.

Currently all branded and generically written prescriptions for Rivaroxaban tablets are reimbursed in line with NHS list prices of the brand originator Xarelto®. However, licensed generic Rivaroxaban tablets have been available in the market for several months following the patent expiry of Xarelto®. Consequently, selling prices of generic Rivaroxaban tablets have fallen sharply when compared [...]

The post Rivaroxaban tablets – changes to reimbursement from September 2024 appeared first on Community Pharmacy England.

A recorded presentation on what lies ahead for community pharmacy – including Community Pharmacy England’s strategy to improve the outlook for pharmacy owners and their teams – is now available to watch on-demand. Spring 2024 saw two key moments for community pharmacy: the end of the five-year CPCF and a General Election campaign. As critical [...]

The post Community Pharmacy England presents strategy to improve outlook for pharmacy appeared first on Community Pharmacy England.

Community pharmacy owners are being asked to share information and views about increasing Pharmacy First thresholds, as well as the impact of GP action, ahead of the next full Community Pharmacy England Committee meeting in September. Many pharmacies may struggle to meet scheduled increases in the threshold for the monthly Pharmacy First payment and pharmacy [...]

The post Share your opinions on Pharmacy First thresholds: Pharmacy Owner Views Sought appeared first on Community Pharmacy England.

Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Drug alert number: EL (24)A/35 MDR number: MDR 113-05/24 Date issued: 08 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Company name: Accord-UK Ltd Product name: Trandolapril 0.5mg [...]

The post MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) appeared first on Community Pharmacy England.